New hope for tough brain cancer: Triple-Drug attack shows promise
Disease control
Recruiting now
This study tests a three-drug combination (selinexor, methotrexate, and rituximab) in 30 adults with central nervous system lymphoma that has relapsed or not responded to treatment. The goal is to find the safest dose and see how well the combo works. Participants receive the dru…
Phase: PHASE1, PHASE2 • Sponsor: Tong Chen, MD • Aim: Disease control
Last updated Jun 26, 2026 18:24 UTC